Joel Moss - Bethesda MD Sally J. Stanley - Silver Spring MD Maria S. Nightingale - Bethesda MD Lucia Monaco - Rome, IT James J. Murtagh - Atlanta GA Tatsuyuki Takada - Rockville MD
Assignee:
The United States of America as represented by the Department of Health and Human Services - Washington DC
International Classification:
C12N 1555 C12N 1510 C12N 1563 C12N 924
US Classification:
4351723
Abstract:
The present invention relates to the production of mammalian ADP-ribosylarginine hydrolases. These enzymes can be manufactured using recombinant DNA technology and are useful in regulation of proteins involved in key metabolic pathways.